Specifically, in breast cancer (BRCA) and head and neck squamous cell carcinoma (HNSC), PRKN, PINK1, and MAP1LC3A were downregulated, while SRC and BECN1 were upregulated. This evidence concerns the gene MAP1LC3A and breast carcinoma.